Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Xellia Pharmaceuticals

www.xellia.com Xellia Pharmaceuticals

Dalslandsgade 11
2300 Copenhagen S
Denmark

+45 3624 5500

Related Companies

  • Gerresheimer
  • Romaco Group
  • Copley Scientific
  • Intelsius
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Autoscribe Informatics
  • Nanoform
  • GEA Pharma and Healthcare
  • Shimadzu UK
  • SGS Health Sciences
  • Starlab
  • Adare Pharma Solutions
  • SCIEX
  • Beamex
  • NSF
  • Burkert Fluid Control Systems
  • Anton Paar

Related Content

Xellia Cleveland manufacturing facility operational for anti-infectives
Xellia Cleveland manufacturing facility operational for anti-infectives
Xellia Pharmaceuticals launches additional Vanco Ready doses
Xellia Pharmaceuticals launches additional Vanco Ready doses
Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Sr Scientist, On Market Products (5942)
Career Opportunities: Sr Scientist, On Market Products (5942)
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Xellia Pharmaceuticals reports strong year for 2019 and key business updates
Xellia Pharmaceuticals reports strong year for 2019 and key business updates
FDA approves Xellia US facility for CMO injectables
FDA approves Xellia US facility for CMO injectables
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals appoints Craig Boyd as President of Xellia US
Xellia Pharmaceuticals appoints Craig Boyd as President of Xellia US
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals signs Davos Declaration on 
combating Antimicrobial Resistance
Xellia Pharmaceuticals signs Davos Declaration on 
combating Antimicrobial Resistance

This website stores data such as cookies to enable site functionality including analytics and personalization. By using this website, you automatically accept that we use cookies.

  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company